These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of physicians as medical review officers in workplace drug testing programs. In pursuit of the last nanogram. Clark HW. West J Med; 1990 May; 152(5):514-24. PubMed ID: 2190419 [Abstract] [Full Text] [Related]
5. Drug testing in the private and public sectors. Walsh JM. Bull N Y Acad Med; 1989 Feb; 65(2):166-72. PubMed ID: 2611451 [No Abstract] [Full Text] [Related]
9. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. Bush DM. Forensic Sci Int; 2008 Jan 30; 174(2-3):111-9. PubMed ID: 17434274 [Abstract] [Full Text] [Related]
10. Workplace urine screening for drug abuse. Wright DS. J Med Ethics; 1997 Jun 30; 23(3):191. PubMed ID: 9220335 [No Abstract] [Full Text] [Related]
11. How state medical marijuana laws affect workplace drug testing. Kenney JE. Occup Health Saf; 2006 Apr 30; 75(4):26, 28, 31. PubMed ID: 16642674 [No Abstract] [Full Text] [Related]
19. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice. Fed Regist; 1991 Jan 02; 56(1):77-8. PubMed ID: 10128596 [Abstract] [Full Text] [Related]
20. Drugs in the workplace: New York State is meeting the challenge. Hodes NL. Empl Benefits J; 1990 Mar 02; 15(1):21-5, 32. PubMed ID: 10104082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]